Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
3(15%)
Results Posted
25%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_1
1
5%
Ph not_applicable
12
60%
Ph phase_3
2
10%
Ph phase_4
1
5%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 3Large-scale testing
2(12.5%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
12(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

20

all time

Status Distribution
Active(3)
Completed(12)
Terminated(2)
Other(3)

Detailed Status

Completed12
unknown3
Recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 32 (12.5%)
Phase 41 (6.3%)
N/A12 (75.0%)

Trials by Status

completed1260%
terminated210%
unknown315%
recruiting315%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06079021Not Applicable

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

Recruiting
NCT05027529Not Applicable

ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock

Completed
NCT05146336

CytOSorb TreatMent Of Critically Ill PatientS Registry

Recruiting
NCT05077124

Safe and Timely Antithrombotic Removal (STAR) Registry

Recruiting
NCT03384875Not Applicable

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery

Terminated
NCT04765748

Cytokine Filter Usage During Open Thoracoabdominal Aortic Aneurysm Repair- a Single-center Randomized Prospective Trial

Completed
NCT05242289Not Applicable

Cytokine Adsorption in Lung Transplantation

Completed
NCT05658588Not Applicable

Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock

Completed
NCT03145441Not Applicable

Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation

Completed
NCT05259514Not Applicable

CytoSorb SAH Trial

Terminated
NCT04518969Not Applicable

Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19

Completed
NCT03945708Not Applicable

Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?

Completed
NCT04533256

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis

Completed
NCT02566525Not Applicable

CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery

Completed
NCT04048434Not Applicable

Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)

Unknown
NCT04157647Not Applicable

Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response

Unknown
NCT02666703Phase 3

Extracorporeal Cytokine Adsorption in Cardiac Surgery

Completed
NCT02775123Phase 1

Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass

Completed
NCT03082469Phase 4

Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal

Unknown
NCT01879176Phase 3

Cytokine Removal in Cardiopulmonary Bypass Patients

Completed

All 20 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
20